Search research articles
Contact Us
Filters
Showing results (51-60 of 99) with videos related to
Page
of 10
Sort By:
European Heart Journal
|
May 15, 2013
Long-term survival in patients with refractory angina
Timothy D Henry, Daniel Satran, James S Hodges, et al.
Circulation Research
|
May 12, 2017
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function
Mahan Shahrivari, Elizabeth Wise, Micheline Resende, et al.
The Journal of Invasive Cardiology
|
November 11, 2003
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results
Kenneth W Mahaffey, Bruce E Lewis, Nancy M Wildermann, et al.
Journal of the American College of Cardiology
|
December 5, 2009
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction
Joshua M Hare, Jay H Traverse, Timothy D Henry, et al.
Scientific Reports
|
March 8, 2018
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Jesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
Basic Research in Cardiology
|
November 25, 2016
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials
Ariadna Contreras, Aaron F Orozco, Micheline Resende, et al.
Circulation Research
|
May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network
Robert D Simari, Carl J Pepine, Jay H Traverse, et al.
Scientific Reports
|
July 2, 2017
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Jesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
European Heart Journal
|
January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
Timothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
April 16, 2020
Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018
Santiago Garcia, Christian W Schmidt, Ross Garberich, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 99) with videos related to
Sort By:
Page
of 10
European Heart Journal
|
May 15, 2013
Long-term survival in patients with refractory angina
Timothy D Henry, Daniel Satran, James S Hodges, et al.
Circulation Research
|
May 12, 2017
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function
Mahan Shahrivari, Elizabeth Wise, Micheline Resende, et al.
The Journal of Invasive Cardiology
|
November 11, 2003
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results
Kenneth W Mahaffey, Bruce E Lewis, Nancy M Wildermann, et al.
Journal of the American College of Cardiology
|
December 5, 2009
A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction
Joshua M Hare, Jay H Traverse, Timothy D Henry, et al.
Scientific Reports
|
March 8, 2018
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Jesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
Basic Research in Cardiology
|
November 25, 2016
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials
Ariadna Contreras, Aaron F Orozco, Micheline Resende, et al.
Circulation Research
|
May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network
Robert D Simari, Carl J Pepine, Jay H Traverse, et al.
Scientific Reports
|
July 2, 2017
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
Jesse V Jokerst, Nicholas Cauwenberghs, Tatiana Kuznetsova, et al.
European Heart Journal
|
January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials
Timothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
April 16, 2020
Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018
Santiago Garcia, Christian W Schmidt, Ross Garberich, et al.
Page
of 10